WAUN K. HONG, M.D.
Osteopathic Medicine at Holcombe Blvd, Houston, TX
License number
Texas G7233
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about WAUN K. HONG at radaris.comName
Address
Phone
6254 Woods Bridge Way, Houston, TX 77007
6254 Woods Bridge Way, Houston, TX 77007
Professional information
Dr. Waun K Hong, Houston TX - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
1515 Holcombe Blvd, Houston 77030
MD Anderson Cnr Ctr Thoracic
1515 Holcombe Blvd, Houston 77030
(713) 792-6110 (Phone)
1515 Holcombe Blvd, Houston 77030
MD Anderson Cnr Ctr Thoracic
1515 Holcombe Blvd, Houston 77030
(713) 792-6110 (Phone)
MD Anderson Cnr Ctr Thoracic
1515 Holcombe Blvd, Houston 77030
(713) 792-6110 (Phone)
1515 Holcombe Blvd, Houston 77030
MD Anderson Cnr Ctr Thoracic
1515 Holcombe Blvd, Houston 77030
(713) 792-6110 (Phone)
Certifications:
Internal Medicine, 1976, Medical Oncology, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
YONSEI UNIVERSITY / COLLEGE OF MEDICINE
Bronx-Lebanon Hosp
Boston VA Hosp
Memorial Sloan-Kettering Cancer Center
YONSEI UNIVERSITY / COLLEGE OF MEDICINE
Bronx-Lebanon Hosp
Boston VA Hosp
Memorial Sloan-Kettering Cancer Center
Waun Ki Hong, Houston TX
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Hematology, Pathology, Anatomic Pathology & Clinical Pathology, Otolaryngology, Occupational Medicine
Work:
MD Anderson Cancer Ctr
1515 Holcombe Blvd, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
Education:
Yonsei University (1967)
Waun Ki Hong, Houston TX
Specialties:
Oncologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Yonsei University, College of Medicine - Doctor of Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Oncology (Internal Medicine)
VA Boston Healthcare System-Jamaica Plain Campus - Residency - Family Medicine
Memorial Sloan-Kettering Cancer Center - Fellowship - Oncology (Internal Medicine)
VA Boston Healthcare System-Jamaica Plain Campus - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Biomarkers For Response To Tyrosine Kinase Pathway Inhibitors In Cancer
US Patent:
2013023, Sep 5, 2013
Filed:
Feb 4, 2013
Appl. No.:
13/758728
Inventors:
Ignacio I. WISTUBA - Houston TX, US
Monique B. NILSSON - Sugar Land TX, US
Lauren A. BYERS - Houston TX, US
Ximing TANG - Houston TX, US
Fei YANG - Houston TX, US
Edward KIM - Houston TX, US
Anne S. TSAO - Houston TX, US
Scott M. LIPPMAN - Houston TX, US
Waun Ki HONG - Houston TX, US
Roy S. HERBST - Houston TX, US
Monique B. NILSSON - Sugar Land TX, US
Lauren A. BYERS - Houston TX, US
Ximing TANG - Houston TX, US
Fei YANG - Houston TX, US
Edward KIM - Houston TX, US
Anne S. TSAO - Houston TX, US
Scott M. LIPPMAN - Houston TX, US
Waun Ki HONG - Houston TX, US
Roy S. HERBST - Houston TX, US
Assignee:
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX
International Classification:
G01N 33/74, A61K 39/395, A61K 31/506, A61K 31/4439, C12Q 1/68, A61K 31/4045
US Classification:
4241331, 435 723, 435 611, 514414, 51425218, 514338
Abstract:
Copy number gains detected in tumors and associated with drug sensitivity and resistance in vivo and in vitro can be used as biomarkers to select, predict and monitor drug treatment outcomes in cancer patients treated with tyrosine kinase inhibitors. Methods to identify patients with NSCLC or other malignancies who are more likely to benefit from tyrosine kinase inhibitors such as VEGF or VEGFR inhibitors when used either as monotherapy or in combination with other therapies such as chemotherapy or EGFR inhibitors, and who are in the advanced stages of disease and/or who have undergone adjuvant therapy are also provided herein.